Despite causing similar body weight changes compared to RYGB and BWM, PYY3-36 + liraglutide treatment does not impact hypothalamic gene expression. Whether this striking difference is favorable or unfavorable to metabolic health in the long term requires further investigation.
Juan Carlos Franco MontoyaElkin Alejandro Osorio Amaya
Sandra GalindoCarlos Mauricio Agudelo RodríguezEsther Julia Olaya-Marín
Paulina Salazar-CortezIván Pérez-Vera
Diana Mirella Martínez PinillaOlga Patricia PáezGloria García